Clinical trials
Thyroid Cancer, Papillary trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
75 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 3 |
| 2004 | 7 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 4 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Terminated | 10 |
| Active, not recruiting | 10 |
| Recruiting | 7 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 18 |
| Hoffmann-La Roche | 4 |
| M.D. Anderson Cancer Center | 4 |
| Massachusetts General Hospital | 4 |
| Eli Lilly and Company | 3 |
| Exelixis | 3 |
| Mayo Clinic | 3 |
| Memorial Sloan Kettering Cancer Center | 3 |
| Academic and Community Cancer Research United | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Cancer, Papillary | 75 |
| Thyroid Neoplasms | 47 |
| Adenocarcinoma, Follicular | 43 |
| Carcinoma, Medullary | 18 |
| Head and Neck Neoplasms | 15 |
| Carcinoma, Non-Small-Cell Lung | 14 |
| Breast Neoplasms | 9 |
| Melanoma | 9 |
| Pancreatic Neoplasms | 9 |
| Colonic Neoplasms | 8 |
Trials
Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.